dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:21:18Z
dc.date.available2014-05-27T11:21:18Z
dc.date.created2014-05-27T11:21:18Z
dc.date.issued2005-04-01
dc.identifierActa Farmaceutica Bonaerense, v. 24, n. 2, p. 246-249, 2005.
dc.identifier0326-2383
dc.identifierhttp://hdl.handle.net/11449/68197
dc.identifier2-s2.0-23044492305
dc.description.abstractFlutamide is a potent antiandrogen used for the treatment of prostatic cancer. A simple, sensitive and accurate high-performance liquid Chromatographic (HPLC) method is presented for quantitative determination of flutamide in tablets, using a reversed-phase technique and UV detection at 240 nm. The isocratic elution was used to quantify the analyte. The samples were chromatographed on Luna-C18 column and the mobile phase was 0.05 M phosphate buffer pH 4.0 - acetonitrile (50:50, v/v). The method was linear between 2.9 - 11.6 mg L -1. Over the tested concentration range the intra-day relative standard deviation for replicate analysis in tablets ranged from 0.44 to 0.78%. It was also found that the excipients in the commercial tablets did not interfere with the method.
dc.languageeng
dc.relationActa Farmaceutica Bonaerense
dc.relation0.401
dc.relation0,152
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectAnalysis in tablets
dc.subjectFlutamide
dc.subjectHigh-performance liquid chromatography (HPLC)
dc.subjectPharmaceutical analysis
dc.subjectacetonitrile
dc.subjectflutamide
dc.subjectdrug determination
dc.subjecthigh performance liquid chromatography
dc.subjectprostate cancer
dc.subjectreversed phase high performance liquid chromatography
dc.subjecttablet
dc.titleDetermination of flutamide in tablets by high-performance liquid chromatography
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución